curvature (Fig 1b) . Enhanced CT showed a small mass in segment 8 of the liver, and this hepatic SOL was suspected to be metastasis of gastric cancer.
The initial laboratory data were as follows : 5300 /μl white blood cell count, 7.8 g/dL hemoglobin, 430,000 /μl platelet count, 19 IU/L aspartate aminotransferase, 13 IU/L alanine aminotransferase, 11 mg/dL blood urea nitrogen, 0.87 mg/dL creatinin, 3.7 g/dL albumin. Tumor markers were as follows : 7 ng/mL alpha-fetoprotein, 1.7 ng/mL carcinoembryonic antigen (CEA), and 38 U/mL carbohydrate antigen (CA) 19-9. He was positive for hepatitis B (HB) surface antibody (HBsAb), HBeAb and HBcAb, and negative for HBsAg and HBeAg.
Plain CT showed a low density mass, 1.1!1.0 cm in size, in segment 8 of the liver. Enhanced CT showed that the mass lesion was gradually enhanced mainly in the marginal border between normal parenchyma and SOL, and the mass was not enhanced compared to parenchyma (iso-density) in the delayed phase (Fig 2) . Magnetic resonance imaging (MRI) showed that the tumor had a low signal on T1-weighted and high signal on T2-weighted images. Hepatobiliary phase of ethoxybenzyl (EOB)-enhanced MRI showed no uptake in the corresponding area, as a defect (Fig 3) . Fluoro-deoxy-glucose positron emission tomography (FDG-PET) showed a b c that FDG accumulated only in gastric tumor (SUVmax 6.8). With these findings, we diagnosed the liver mass as metastasis of gastric cancer (Stage IV). In this case, chemotherapy is recommended according to gastric cancer treatment guideline. However, we performed distal gastrectomy in order to control the bleeding from gastric cancer.
Operative fingngs and resected specimens
With fully informed consents for a possible hepatic malignant tumor, we performed distal gastrectomy. The edge of the liver was sharp, and liver surface was smooth. As intraoperative echography revealed that the liver mass of segment 8 was near the liver surface, wedge resection of segment 8 of the liver was also performed. The resected specimen of the liver showed a well demarcated homogenous white solid mass, 0.8!0.7 cm in size, elastic hard (Fig 4) . Histrogical examinations showed that most area comprised hyalinized tissue and collagen fibers with small and thin-walled vascular space (Fig 5a) . Immunohistochemical staining revealed some vascular components, as shown by positive CD34 in its peripheral region (Fig 5b) (Fig 5c) . From these characteristics, the tumor was finally diagnosed as a hepatic sclerosed hemangioma. Final diagnosis of gastric cancer was T3(ss), N2, ly2, v1, M0 (Stage IIIb).
DISCUSSION
Cavernous hemangioma of the liver is the most frequent, the reported incidence being as high as 20% in liver tumor (4). The high incidence of hemangioma increases the probability of encountering atypical manifestations, including necrosis, scarring, and calcification. A sclerosed hemangioma is the ultimate form having all these degenerative changes, and such varaeties of pathological characteristics make precisely radiological diagnosis very difficult (5) .
In our case, plain CT showed hepatic screlosed hemanangioma as low density, and enhanced CT showed a ring enhancement pattern, which is characteristic of adenocarcinoma. Although cavernous hemangioma shows typical features : low density on plain CT and delayed pooling enhancement, many previous reports have not shown this feature in sclerosed hemangioma (5) (6) (7) (8) (9) (10) (11) (12) . MRI finding in our case was fit to typical feature of cavernous hemangioma, such as low on T1 and high on T2 weighted images, but this feature can be also observed in the cases of metastatic liver tumors and cholangiocellular carcinoma. Others also reported that MRI findings of sclerosed hemangioma were different from the typical cavernous hemangioma (5-11). It was reported that nodular areas of reduced signal intensity on T2-weighted images corresponded to the histological finding of fibrosis (13) . A complicating factor is the contribution to signal heterogeneity of hemorrhage, thrombosis, hyalinization, calcification, and cystic cavities (13) . On the otherhand, in our case, FDG accumulated only in gastric tumor, not in hepatic tumor in FDG-PET scan. However, the size of hepatic tumor was so small that this finding could not eliminate the malignancy. With the fact that there was advanced gastric cancer and these radiological findings, metastatic liver tumor from gastric cancer could not be excluded. It has reported that the findings such as geographical pattern, capsular-retraction, decrease in size in follow-ups, and vanishing of previous enhanced lesion should raise the possibility of the presence of screlosed hemangioma, and it can be diagnosed with biopsy before surgical intervention (5). However, we do not agree the universal application of perctaneous needle biopsy to make a definite diagnosis of hepatic tumor such as present case. Becouse a percutaneous biopsy has been reported to have a potential risk of abdominal dissemination by needle tract implantation (14) . As hepatic resection has been safe procedure in recent years (15, 16) , hepatic resection should be chosen as a first strategy for tumors with unknown pathologically malignant potential.
Although sclerosed hemangioma is a rare disease among hepatic tumors, it needs to be taken into consideration among differential diagnosis of hepatic tumors. As it was extremely difficult to differentiate the lesion from liver metastasis or cholangiocellarcarcinoma, if the malignancy of the tumor cannot be denied, hepatic resection should be chosen for diagnostic therapy.
